Chemours Co Stock EBITDA
| CC Stock | USD 26.48 0.11 0.42% |
Chemours Co fundamentals help investors to digest information that contributes to Chemours' financial success or failures. It also enables traders to predict the movement of Chemours Stock. The fundamental analysis module provides a way to measure Chemours' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemours stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 220 M | 209 M |
Chemours | EBITDA |
Chemours Co Company EBITDA Analysis
Chemours' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Chemours EBITDA | 220 M |
Most of Chemours' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemours Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Chemours EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Chemours is extremely important. It helps to project a fair market value of Chemours Stock properly, considering its historical fundamentals such as EBITDA. Since Chemours' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemours' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemours' interrelated accounts and indicators.
Click cells to compare fundamentals
Chemours EBITDA Historical Pattern
Today, most investors in Chemours Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Chemours' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Chemours ebitda as a starting point in their analysis.
Chemours EBITDA |
| Timeline |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Chemours Ebitda
Ebitda |
|
According to the company disclosure, Chemours Co reported earnings before interest,tax, depreciation and amortization of 220 M. This is 72.34% lower than that of the Chemicals sector and 74.21% lower than that of the Materials industry. The ebitda for all United States stocks is 94.36% higher than that of the company.
Chemours EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemours' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemours could also be used in its relative valuation, which is a method of valuing Chemours by comparing valuation metrics of similar companies.Chemours is currently under evaluation in ebitda category among related companies.
Chemours Current Valuation Drivers
We derive many important indicators used in calculating different scores of Chemours from analyzing Chemours' financial statements. These drivers represent accounts that assess Chemours' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemours' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 5.0B | 3.0B | 4.1B | 4.8B | 4.7B | 3.6B | |
| Enterprise Value | 7.8B | 6.4B | 7.3B | 7.5B | 7.2B | 5.3B |
Chemours Institutional Holders
Institutional Holdings refers to the ownership stake in Chemours that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chemours' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chemours' value.| Shares | Geode Capital Management, Llc | 2023-12-31 | 2.3 M | American Century Companies Inc | 2023-12-31 | 1.4 M | Vaughan Nelson Scarbrgh & Mccullough Lp | 2023-12-31 | 1.4 M | Goldman Sachs Group Inc | 2023-12-31 | 1.3 M | Norges Bank | 2023-12-31 | 1.2 M | Charles Schwab Investment Management Inc | 2023-12-31 | 1.1 M | Northern Trust Corp | 2023-12-31 | 1.1 M | Legal & General Group Plc | 2023-12-31 | 1.1 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1 M | Blackrock Inc | 2023-12-31 | 16.5 M | Fmr Inc | 2023-12-31 | 16.4 M |
Chemours Fundamentals
| Return On Equity | -0.26 | |||
| Return On Asset | 0.0529 | |||
| Profit Margin | (0.04) % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 7.03 B | |||
| Shares Outstanding | 148.88 M | |||
| Shares Owned By Insiders | 0.59 % | |||
| Shares Owned By Institutions | 76.97 % | |||
| Number Of Shares Shorted | 4.88 M | |||
| Price To Earning | 25.49 X | |||
| Price To Book | 5.35 X | |||
| Price To Sales | 0.65 X | |||
| Revenue | 6.03 B | |||
| Gross Profit | 1.62 B | |||
| EBITDA | 220 M | |||
| Net Income | (238 M) | |||
| Cash And Equivalents | 1.1 B | |||
| Cash Per Share | 7.73 X | |||
| Total Debt | 4.3 B | |||
| Debt To Equity | 2.94 % | |||
| Current Ratio | 1.82 X | |||
| Book Value Per Share | 4.96 X | |||
| Cash Flow From Operations | 556 M | |||
| Short Ratio | 1.37 X | |||
| Earnings Per Share | (1.60) X | |||
| Price To Earnings To Growth | 1.67 X | |||
| Target Price | 31.44 | |||
| Number Of Employees | 6.2 K | |||
| Beta | 2.02 | |||
| Market Capitalization | 3.93 B | |||
| Total Asset | 8.25 B | |||
| Retained Earnings | 1.78 B | |||
| Working Capital | 1.35 B | |||
| Current Asset | 2.3 B | |||
| Current Liabilities | 1.47 B | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 3.59 % | |||
| Net Asset | 8.25 B | |||
| Last Dividend Paid | 1.0 |
About Chemours Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chemours Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemours using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemours Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Chemours Investors Sentiment
The influence of Chemours' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chemours. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Chemours' public news can be used to forecast risks associated with an investment in Chemours. The trend in average sentiment can be used to explain how an investor holding Chemours can time the market purely based on public headlines and social activities around Chemours Co. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Chemours' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Chemours' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Chemours' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Chemours.
Chemours Implied Volatility | 287.57 |
Chemours' implied volatility exposes the market's sentiment of Chemours Co stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Chemours' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Chemours stock will not fluctuate a lot when Chemours' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chemours in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chemours' short interest history, or implied volatility extrapolated from Chemours options trading.
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Moving against Chemours Stock
| 0.64 | DNMR | Danimer Scientific Financial Report 8th of May 2024 | PairCorr |
| 0.59 | ECL | Ecolab Inc Financial Report 7th of May 2024 | PairCorr |
| 0.58 | FEAM | 5E Advanced Materials Financial Report 9th of May 2024 | PairCorr |
| 0.56 | CMT | Core Molding Technologies Financial Report 14th of May 2024 | PairCorr |
| 0.51 | ASH | Ashland Global Holdings Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Chemours Piotroski F Score and Chemours Altman Z Score analysis. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.